Standout Papers

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea a... 2003 2026 2010 2018 576
  1. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group (2003)
    Paul J. Hesketh, Steven M. Grunberg et al. Journal of Clinical Oncology

Immediate Impact

3 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis
2024 StandoutNature
The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial
2023 Standout
1 intermediate paper

Works of Klaus Beck being referenced

Impact of sepsis, lung injury, and the role of lipid infusion on circulating prostacyclin and thromboxane A2
2002
Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Klaus Beck 552 110 86 354 10 820
M. Schumer 188 161 86 264 11 984
Preston R. Black 273 113 158 144 13 702
Arham Ali 171 59 72 322 7 715
Susanne Herroeder 411 24 41 77 10 710
H R Keiser 115 98 94 265 10 891
R S Sherwin 259 118 72 263 18 880
F.R. House 241 235 231 192 13 882
Antonio Milena 156 76 85 182 16 855
Anders Dejgård 263 12 29 560 13 899
Neil I. Kaminsky 116 52 144 141 13 865

All Works

Loading papers...

Rankless by CCL
2026